Distinguished in Atherosclerosis

Masaaki Uematsu

Tokyo, JP 
Distinguished in Atherosclerosis
Tokyo, JP 
OverviewLocationsClinical Research

Overview

Masaaki Uematsu practices in Tokyo, Japan. Mr. Uematsu is rated as a Distinguished expert by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Peripheral Artery Disease, Heart Failure with Preserved Ejection Fraction (HFpEF), Atherosclerosis, Stent Placement, and Angioplasty.

His clinical research consists of co-authoring 124 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 31 articles and participated in 1 clinical trial in the study of Atherosclerosis.

Gender
Male

Locations

Tokyo, Japan
Other Locations
Shinjuku, Japan
Osaka, Japan
Hongo, Japan
Chuo, 5400006, Japan
Amagasaki, Japan
Japan
Kyoto, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized Trial Comparing the ELUVIA™ Drug-eluting Stent Versus Zilver® PTX® Stent for Treatment of Superficial Femoral and/or Proximal Popliteal Arteries
A Randomized Trial Comparing the ELUVIA™ Drug-eluting Stent Versus Zilver® PTX® Stent for Treatment of Superficial Femoral and/or Proximal Popliteal Arteries
Enrollment Status: Completed
Publish Date: May 08, 2023
Intervention Type: Device
Study Phase: Not Applicable
Prospective, Single Arm, Multi-centre, Observational Registry to Further Validate Safety and Efficacy of the Ultimaster Des System in Unselected Patients Representing Everyday Clinical Practice
Prospective, Single Arm, Multi-centre, Observational Registry to Further Validate Safety and Efficacy of the Ultimaster Des System in Unselected Patients Representing Everyday Clinical Practice
Enrollment Status: Unknown
Publish Date: October 08, 2019
View 1 Less Clinical Trial

124 Total Publications

Barcode-free multiplex plasmid sequencing using Bayesian analysis and nanopore sequencing.
Barcode-free multiplex plasmid sequencing using Bayesian analysis and nanopore sequencing.
Journal: eLife
Published: April 25, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Uematsu's expertise for a condition
ConditionClose
View All 9 Advanced Conditions
View All 14 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile